{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:55:41Z","timestamp":1783407341425,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["17303-JHUSOM"],"award-info":[{"award-number":["17303-JHUSOM"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40615-023-01780-6","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T15:02:11Z","timestamp":1694185331000},"page":"3249-3259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["\u201cThe Patient Should Have a Choice\u201d: Adults with Sickle Cell Disease Advise Integration of Telemedicine into the Comprehensive Sickle Cell Disease Care Model"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-9752","authenticated-orcid":false,"given":"Lydia H.","family":"Pecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ruvalcaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Lanzkron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle N.","family":"Eakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"1780_CR1","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","volume":"4","author":"J Kanter","year":"2020","unstructured":"Kanter J, Smith WR, Desai PC, et al. Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects. Blood Adv. 2020;4:3804\u201313.","journal-title":"Blood Adv"},{"key":"1780_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/tmj.1.1998.4.353","volume":"4","author":"K Woods","year":"1998","unstructured":"Woods K, Kutlar A, Grigsby RK, et al. Primary-care delivery for sickle cell patients in rural Georgia using telemedicine. Telemed J. 1998;4:353\u201361.","journal-title":"Telemed J"},{"key":"1780_CR3","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1056\/NEJMp2005835","volume":"382","author":"S Keesara","year":"2020","unstructured":"Keesara S, Jonas A, Schulman K. Covid-19 and health care\u2019s digital revolution. New Engl J Med. 2020;382:e82.","journal-title":"New Engl J Med"},{"key":"1780_CR4","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1097\/MPH.0000000000002008","volume":"43","author":"ML Noisette","year":"2020","unstructured":"Noisette ML, Phillips S, Schlenz AM, et al. Changes in care delivery for children with sickle cell anemia during the COVID-19 pandemic. J Pediatric Hematol Oncol. 2020;43:e1231\u20134.","journal-title":"J Pediatric Hematol Oncol"},{"key":"1780_CR5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1089\/tmj.2021.0132","volume":"28","author":"SL Reeves","year":"2022","unstructured":"Reeves SL, Patel PN, Madden B, et al. Telehealth use before and during the COVID-19 pandemic among children with sickle cell anemia. Telemed E-health. 2022;28:1166\u201371.","journal-title":"Telemed E-health"},{"key":"1780_CR6","first-page":"349","volume":"5","author":"KF Woods","year":"1999","unstructured":"Woods KF, Kutlar A, Johnson JA, et al. Sickle cell telemedicine and standard clinical encounters: a comparison of patient satisfaction. Telemed J Off J Am Telemed Assoc. 1999;5:349\u201356.","journal-title":"Telemed J Off J Am Telemed Assoc"},{"key":"1780_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1258\/1357633001935923","volume":"6","author":"KF Woods","year":"2000","unstructured":"Woods KF, Johnson JA, Kutlar A, et al. Sickle cell disease telemedicine network for rural outreach. J Telemed Telecare. 2000;6:285\u201390.","journal-title":"J Telemed Telecare"},{"key":"1780_CR8","doi-asserted-by":"publisher","unstructured":"Pace BS. Telemedicine expands hydroxyurea monitoring for children living with sickle cell disease in rural south Georgia. Biomed J Sci Technical Res; 22. Epub ahead of print 2019. https:\/\/doi.org\/10.26717\/bjstr.2019.22.003697.","DOI":"10.26717\/bjstr.2019.22.003697"},{"key":"1780_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12913-022-07627-w","volume":"22","author":"SA Jacob","year":"2021","unstructured":"Jacob SA, Daas R, Feliciano A, et al. Caregiver experiences with accessing sickle cell care and the use of telemedicine. Bmc Health Serv Res. 2021;22:239.","journal-title":"Bmc Health Serv Res"},{"key":"1780_CR10","doi-asserted-by":"publisher","first-page":"e29354","DOI":"10.1002\/pbc.29354","volume":"68","author":"S Shaner","year":"2021","unstructured":"Shaner S, Hilliard L, Howard T, et al. Impact of telehealth visits on hydroxyurea response in sickle cell anemia. Pediatr Blood Cancer. 2021;68:e29354.","journal-title":"Pediatr Blood Cancer"},{"key":"1780_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5055\/jom.2021.0683","volume":"17","author":"MO Kenney","year":"2021","unstructured":"Kenney MO, Becerra B, Beatty SA, et al. Telehealth acceptability and opioid prescribing patterns of providers of painful chronic diseases during the COVID-19 pandemic: a survey of sickle cell providers. J Opioid Manag. 2021;17:489\u201397.","journal-title":"J Opioid Manag"},{"key":"1780_CR12","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202101190","volume":"174","author":"LH Pecker","year":"2021","unstructured":"Pecker LH, Lanzkron S. Sickle cell disease. Ann Intern Med. 2021;174:ITC1\u201316.","journal-title":"Ann Intern Med"},{"key":"1780_CR13","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1001\/jama.2010.562","volume":"303","author":"EP Vichinsky","year":"2010","unstructured":"Vichinsky EP, Neumayr LD, Gold JI, et al. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA. 2010;303:1823\u201331.","journal-title":"JAMA"},{"key":"1780_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/bjh.18188","volume":"198","author":"ML Early","year":"2021","unstructured":"Early ML, Linton E, Bosch A, et al. The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: associations with clinically significant cognitive domains. Brit J Haematol. 2021;198:382\u201390.","journal-title":"Brit J Haematol"},{"key":"1780_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2019.04.011","volume":"705","author":"LH Pecker","year":"2019","unstructured":"Pecker LH, Darbari DS. Psychosocial and affective comorbidities in sickle cell disease. Neurosci Lett. 2019;705:1\u20136.","journal-title":"Neurosci Lett"},{"key":"1780_CR16","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3201\/eid2610.202792","volume":"26","author":"JA Panepinto","year":"2020","unstructured":"Panepinto JA, Brandow A, Mucalo L, et al. Coronavirus disease among persons with sickle cell disease, United States, March 20\u2013May 21, 2020. Emerg Infect Dis. 2020;26:2473\u20136.","journal-title":"Emerg Infect Dis"},{"key":"1780_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0033-3549(04)50214-5","volume":"118","author":"J Telfair","year":"2003","unstructured":"Telfair J, Haque A, Etienne M, et al. Rural\/urban differences in access to and utilization of services among people in Alabama with sickle cell disease. Public Health Rep. 2003;118:27\u201336.","journal-title":"Public Health Rep"},{"key":"1780_CR18","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1353\/hpu.2020.0105","volume":"31","author":"S Vais","year":"2020","unstructured":"Vais S, Thomson L, Williams A, et al. Rethinking rideshares: a transportation assistance pilot for pediatric patients with sickle cell disease. J Health Care Poor U. 2020;31:1457\u201370.","journal-title":"J Health Care Poor U"},{"issue":"3","key":"1780_CR19","doi-asserted-by":"publisher","first-page":"e30125","DOI":"10.1002\/pbc.30125","volume":"70","author":"B Speller-Brown","year":"2022","unstructured":"Speller-Brown B, Carhuas C, Stone A, et al. Telemedicine in sickle cell disease: patient, parent, and provider perspectives. Pediatr Blood Cancer. 2022;70(3):e30125.","journal-title":"Pediatr Blood Cancer"},{"key":"1780_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/1357633X19883558","volume":"27","author":"SA Jacob","year":"2019","unstructured":"Jacob SA, Carroll AE, Bennett WE. A feasibility study of telemedicine for paediatric sickle cell patients living in a rural medically underserved area. J Telemed Telecare. 2019;27:431\u20135.","journal-title":"J Telemed Telecare"},{"key":"1780_CR21","doi-asserted-by":"publisher","unstructured":"Zhang S, Xue W, Boorman EP, et al. Accessible care with high patient satisfaction: telemedicine use in sickle cell disease. Telemed E-health. Epub ahead of print 2022. https:\/\/doi.org\/10.1089\/tmj.2022.0387.","DOI":"10.1089\/tmj.2022.0387"},{"key":"1780_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care\u202f: J Int Soc Qual Health Care. 2007;19:349\u201357.","journal-title":"Int J Qual Health Care : J Int Soc Qual Health Care"},{"key":"1780_CR23","doi-asserted-by":"publisher","unstructured":"Braun, V., & Clarke, V. Thematic analysis. In H. Cooper, P. M. Camic, D. L. Long, A. T. Panter, D. Rindskopf, & K. J. Sher, editors. APA handbook of research methods in psychology, Vol. 2. Research designs: quantitative, qualitative, neuropsychological, and biological. Washington DC: American Psychological Association; 2012. 57\u201371. https:\/\/doi.org\/10.1037\/13620-004","DOI":"10.1037\/13620-004"},{"key":"1780_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/AJP.0000000000000054","volume":"30","author":"MJ Treadwell","year":"2014","unstructured":"Treadwell MJ, Hassell K, Levine R, et al. Adult sickle cell quality-of-life measurement information system (ASCQ-Me). Clin J Pain. 2014;30:902\u201314.","journal-title":"Clin J Pain"},{"key":"1780_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1080\/13803395.2016.1149153","volume":"38","author":"M Sanger","year":"2016","unstructured":"Sanger M, Jordan L, Pruthi S, et al. Cognitive deficits are associated with unemployment in adults with sickle cell anemia. J Clin Exp Neuropsyc. 2016;38:661\u201371.","journal-title":"J Clin Exp Neuropsyc"},{"key":"1780_CR26","doi-asserted-by":"publisher","first-page":"e20201586","DOI":"10.1542\/peds.2020-1586","volume":"146","author":"MW Katzow","year":"2020","unstructured":"Katzow MW, Steinway C, Jan S. Telemedicine and health disparities during COVID-19. Pediatrics. 2020;146:e20201586.","journal-title":"Pediatrics"},{"key":"1780_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jval.2021.02.014","volume":"24","author":"D Holdford","year":"2021","unstructured":"Holdford D, Vendetti N, Sop DM, et al. Indirect economic burden of sickle cell disease. Value Health. 2021;24:1095\u2013101.","journal-title":"Value Health"},{"key":"1780_CR28","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/jgc4.1410","volume":"30","author":"S Desine","year":"2021","unstructured":"Desine S, Eskin L, Bonham VL, et al. Social support networks of adults with sickle cell disease. J Genet Couns. 2021;30:1418\u201327.","journal-title":"J Genet Couns"},{"key":"1780_CR29","doi-asserted-by":"publisher","first-page":"4070547","DOI":"10.1155\/2017\/4070547","volume":"2017","author":"DK McClish","year":"2017","unstructured":"McClish DK, Smith WR, Levenson JL, et al. Comorbidity, pain, utilization, and psychosocial outcomes in older versus younger sickle cell adults: the PiSCES project. Biomed Res Int. 2017;2017:4070547\u2013610.","journal-title":"Biomed Res Int"},{"key":"1780_CR30","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.7326\/M20-7171","volume":"174","author":"S Lanzkron","year":"2021","unstructured":"Lanzkron S, Little J, Wang H, et al. Treatment of acute pain in adults with sickle cell disease in an infusion center versus the emergency department: a multicenter prospective cohort study. Ann Intern Med. 2021;174:1207\u201313.","journal-title":"Ann Intern Med"},{"key":"1780_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ajh.23961","volume":"90","author":"S Lanzkron","year":"2015","unstructured":"Lanzkron S, Carroll CP, Hill P, et al. Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis. Am J Hematol. 2015;90:376\u201380.","journal-title":"Am J Hematol"},{"issue":"9","key":"1780_CR32","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00277-023-05365-5","volume":"102","author":"M Chen","year":"2023","unstructured":"Chen M, Ataga KI, Hankins JS, et al. Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease. Ann Hematol. 2023;102(9):2329\u201342.","journal-title":"Ann Hematol"},{"key":"1780_CR33","doi-asserted-by":"publisher","first-page":"e43604","DOI":"10.2196\/43604","volume":"25","author":"C Williams","year":"2023","unstructured":"Williams C, Shang D. Telehealth usage among low-income racial and ethnic minority populations during the COVID-19 pandemic: retrospective observational study. J M\u00e9d Internet Res. 2023;25:e43604.","journal-title":"J M\u00e9d Internet Res"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-023-01780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-023-01780-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-023-01780-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T15:15:56Z","timestamp":1734621356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-023-01780-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1780"],"URL":"https:\/\/doi.org\/10.1007\/s40615-023-01780-6","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LHP receives research funding from the NIH\/NHLBI K23HL146841, The Doris Duke Foundation Grant #2020147, American Society of Hematology, Mellon Foundation, and Alexion and is a consultant for Global Blood Therapeutics and Novo Nordisk. SL receives research funding from Imara, Novartis, Global Blood Therapeutics, Takeda, CSL-Behring, HRSA, PCORI, and MD CHRC; consultancy for Bluebird bio, Novo Nordisk, Pfizer, and Magenta; and owns stock in Pfizer and Teva. MNE and ER have no disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}